HealthLynked Corp (HLYK) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
1265 CREEKSIDE PARKWAY NAPLES, FL 34108 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| Industry (SIC) | 8011 - Offices and Clinics of Doctors of Medicine (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 247 | 62 | 3,292 | 162 | 110 | 136 | |||
| Cash and cash equivalent | 247 | 62 | 3,292 | 162 | 110 | 136 | |||
| Receivables | 1,874 | 72 | 86 | 87 | 83 | 115 | |||
| Inventory, net of allowances, customer advances and progress billings | 133 | 193 | 135 | 95 | 70 | ||||
| Inventory | 133 | 193 | 135 | 95 | 70 | ||||
| Prepaid expense | 125 | 119 | 29 | ||||||
| Deferred costs | 19 | 96 | |||||||
| Asset, held-for-sale, not part of disposal group | 1,455 | ||||||||
| Other current assets | |||||||||
| Other undisclosed current assets | (1,598) | 363 | 13 | 59 | |||||
| Total current assets: | 656 | 2,145 | 3,650 | 404 | 403 | 375 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 936 | 540 | ✕ | ||||||
| Property, plant and equipment | 291 | 413 | 350 | 437 | 514 | 43 | |||
| Intangible assets, net (including goodwill) | 1,204 | 1,432 | 6,028 | 6,750 | 1,337 | ||||
| Goodwill | 320 | 320 | 1,148 | 1,148 | 72 | ||||
| Intangible assets, net (excluding goodwill) | 884 | 1,112 | 4,880 | 5,602 | 1,265 | ||||
| Regulated entity, other noncurrent assets | 166 | ||||||||
| Deposits noncurrent assets | 139 | 10 | |||||||
| Other undisclosed noncurrent assets | 1,027 | 51 | 527 | 436 | 293 | ||||
| Total noncurrent assets: | 3,624 | 2,436 | 7,044 | 7,623 | 2,144 | 52 | |||
| TOTAL ASSETS: | 4,280 | 4,581 | 10,695 | 8,027 | 2,547 | 427 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 612 | 1,603 | 791 | 1,892 | 836 | 394 | |||
| Accounts payable | 251 | 864 | 306 | ||||||
| Accrued liabilities | 91 | 673 | 173 | ||||||
| Other undisclosed accounts payable and accrued liabilities | 269 | 66 | 312 | 1,892 | 836 | 394 | |||
| Deferred revenue | 272 | 575 | 73 | 89 | ✕ | ||||
| Debt | 584 | 450 | 61 | 723 | 1,744 | 1,062 | |||
| Deferred compensation liability | 75 | ||||||||
| Derivative instruments and hedges, liabilities | 89 | 991 | 800 | ||||||
| Disposal group, including discontinued operation | 25 | ||||||||
| Business combination, contingent consideration, liability | 100 | 403 | 702 | 500 | |||||
| Other liabilities | 2 | ||||||||
| Due to related parties | ✕ | ✕ | 168 | 301 | 301 | 493 | 430 | ||
| Other undisclosed current liabilities | 942 | 479 | 289 | 1,086 | 744 | 672 | |||
| Total current liabilities: | 2,412 | 3,475 | 1,918 | 4,882 | 5,309 | 3,359 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 45 | 378 | 996 | 81 | 3 | ||||
| Long-term debt, excluding current maturities | 45 | 139 | 723 | ||||||
| Capital lease obligations | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 3 | ||
| Liabilities, other than long-term debt | 613 | 198 | |||||||
| Operating lease, liability | 613 | 198 | 239 | 274 | 81 | ✕ | |||
| Other undisclosed noncurrent liabilities | 450 | 548 | 956 | 525 | |||||
| Total noncurrent liabilities: | 1,063 | 792 | 1,573 | 1,795 | 81 | 3 | |||
| Total liabilities: | 3,475 | 4,266 | 3,491 | 6,677 | 5,389 | 3,362 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | 805 | 314 | 7,204 | 1,350 | (2,843) | (2,935) | |||
| Preferred stock | 3 | 3 | 3 | 3 | |||||
| Common stock | 28 | 26 | 24 | 19 | 11 | 9 | |||
| Additional paid in capital | 42,526 | 41,081 | 39,100 | 22,851 | 13,016 | 7,532 | |||
| Deferred compensation equity | (65) | (151) | |||||||
| Accumulated deficit | (42,033) | (41,021) | (32,205) | (21,785) | (16,030) | (10,501) | |||
| Other undisclosed equity, attributable to parent | 346 | 226 | 434 | 262 | 160 | 26 | |||
| Total equity: | 805 | 314 | 7,204 | 1,350 | (2,843) | (2,935) | |||
| TOTAL LIABILITIES AND EQUITY: | 4,280 | 4,581 | 10,695 | 8,027 | 2,547 | 427 | |||
Income Statement (P&L) ($ in thousands)
| 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 5,722 | 5,858 | 9,198 | 6,133 | 4,019 | 2,259 | ||
| Cost of revenue (Other Cost of Operating Revenue) | (340) | |||||||
| Gross profit: | 5,722 | 5,518 | 9,198 | 6,133 | 4,019 | 2,259 | ||
| Operating expenses | (9,874) | (14,518) | (14,241) | (9,205) | (7,228) | (5,231) | ||
| Other undisclosed operating income | 340 | |||||||
| Operating loss: | (4,152) | (8,659) | (5,043) | (3,072) | (3,209) | (2,972) | ||
| Nonoperating income (expense) | 538 | (23) | (5,369) | (2,683) | (2,320) | (2,819) | ||
| Investment income, nonoperating | 209 | (589) | (870) | |||||
| Gain on condemnation | 1,091 | |||||||
| Debt instrument, convertible, beneficial conversion feature | 825 | |||||||
| Interest and debt expense | (21) | (431) | (4,957) | (382) | (122) | (141) | ||
| Loss from continuing operations before equity method investments, income taxes: | (3,635) | (9,113) | (15,370) | (6,137) | (5,650) | (5,932) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | 21 | 1,045 | 4,957 | 382 | 122 | 141 | ||
| Loss from continuing operations: | (3,614) | (8,067) | (10,413) | (5,755) | (5,529) | (5,791) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (10,413) | (5,755) | (5,529) | (5,791) | |
| Income (loss) from discontinued operations | 2,602 | (748) | ||||||
| Net loss attributable to parent: | (1,012) | (8,816) | (10,413) | (5,755) | (5,529) | (5,791) | ||
| Preferred stock dividends and other adjustments | (446) | |||||||
| Other undisclosed net loss available to common stockholders, basic | (354) | (354) | ||||||
| Net loss available to common stockholders, diluted: | (1,012) | (9,169) | (10,766) | (6,201) | (5,529) | (5,791) | ||
Comprehensive Income ($ in thousands)
| 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (1,012) | (8,816) | (10,413) | (5,755) | (5,529) | (5,791) | ||
| Comprehensive loss, net of tax, attributable to parent: | (1,012) | (8,816) | (10,413) | (5,755) | (5,529) | (5,791) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.